HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2007.082628v1 63/2/135    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horsley, A R Articles by Innes, J A Search for Related Content PubMed PubMed Citation Articles by Horsley, A R Articles by Innes, J A

Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis

¹ School of Clinical and Molecular Medicine, University of Edinburgh, Edinburgh, UK
² Queen Silvia Children’s Hospital, Gothenburg, Sweden
³ Royal Hospital for Sick Children, Edinburgh, UK
⁴ Department of Gene Therapy, National Heart and Lung Institute, Imperial College, London, UK
⁵ UK Cystic Fibrosis Gene Therapy Consortium, UK

Correspondence to:
Dr A R Horsley, Medical Genetics, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK; alex.horsley{at}ed.ac.uk

Background: Lung clearance index (LCI) is a sensitive marker of early lung disease in children but has not been assessed in adults. Measurement is hindered by the complexity of the equipment required. The aims of this study were to assess performance of a novel gas analyser (Innocor) and to use it as a clinical tool for the measurement of LCI in cystic fibrosis (CF).

Methods: LCI was measured in 48 healthy adults, 12 healthy school-age children and 33 adults with CF by performing an inert gas washout from 0.2% sulfur hexafluoride (SF₆). SF₆ signal:noise ratio and 10–90% rise time of Innocor were compared with a mass spectrometer used in similar studies in children.

Results: Compared with the mass spectrometer, Innocor had a superior signal:noise ratio but a slower rise time (150 ms vs 60 ms) which may limit its use in very young children. Mean (SD) LCI in healthy adults was significantly different from that in patients with CF: 6.7 (0.4) vs 13.1 (3.8), p<0.001. Ten of the patients with CF had forced expiratory volume in 1 s 80% predicted but only one had a normal LCI. LCI repeats were reproducible in all three groups of subjects (mean intra-visit coefficient of variation ranged from 3.6% to 5.4%).

Conclusions: Innocor can be adapted to measure LCI and affords a simpler alternative to a mass spectrometer. LCI is raised in adults with CF with normal spirometry, and may prove to be a more sensitive marker of the effects of treatment in this group.

This article has been cited by other articles:

				A. Bush Update in Pediatric Lung Disease 2007 Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 686 - 695. [Full Text] [PDF]

				P. Latzin, C. Thamrin, and R. Kraemer Ventilation inhomogeneities assessed by the multibreath washout (MBW) technique Thorax, February 1, 2008; 63(2): 98 - 99. [Full Text] [PDF]